Pharmacy

With the recent tariffs imposed by President Donald Trump, experts are warning that new trade barriers could jeopardize the supply of heparin, an inexpensive and widely used anticoagulant critical for millions of hospitalized patients, The Washington Post reported April 13.…

The FDA will begin replacing animal testing in the development of monoclonal antibody therapies and other drugs with human-based methods.  The agency said the new approach will aim to improve drug safety, speed up the evaluation process, reduce the use…

Starting April 10, CivicaScript will offer its new drug, droxidopa, for $2,100 less than the average monthly price paid by a Medicare Part D beneficiary.  CivicaScript members, which include more than a dozen Blue Cross Blue Shield companies, said droxidopa…

More than one-third (41%) of active drug shortages began in 2022 or earlier, according to a new report from the American Society of Health-System Pharmacists.  The report tracks national drug shortage trends from January 2001 through March 2025. So far…

Here are six new shortages and discontinuations for April, according to drug supply databases from the FDA and the American Society of Health-System Pharmacists.  Editor’s note: The drugs listed are in alphabetical order. 

At some health systems and hospitals, AI technology is taking the burden of nonclinical, tedious tasks off the hands of pharmacy workers, according to an April 8 article on the American Society of Health-System Pharmacists’ website.  For example, a large…

The American Society of Health-System Pharmacists is calling on pharmacy leaders to mobilize as Congress weighs sweeping federal spending cuts, including up to $880 billion in healthcare reductions primarily to Medicaid.  During a panel held at the recent American College…

A new analysis suggests the benefits of medications used to treat attention-deficit hypersensitivity disorder outweigh any potential cardiovascular risks.  Here are four things to know: 

A few weeks after Sarepta Therapeutics confirmed a patient died after receiving its drug Elevidys, research published April 3 in Gene Therapy suggests the body’s natural immune system might be impairing the therapy’s efficacy.  The FDA approved Elevidys in June…

Walgreens Boots Alliance reported a $5.6 billion operating loss in its fiscal second quarter, an improvement from the $13.2 billion loss in the same period last year as the troubled retailer continues to prepare for a private equity buyout.  Operating…